In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
To Invest or Not: BetterLife Pharma (BETR.C)
Latest Articles
- Brazil Potash (GRO.NYSE) bets big on domestic supply as global potash politics simmer
- Emerita Resources (EMO.V) legal battle may be set to pay off this month
- Highballer Report: Gold’s big run and the juniors benefitting
- Prospera Energy (PEI.V) with no money to pay creditors, buys chairman Shubham Garg’s debt
- Highballer Roundup: Goliath Resources, Amarc Resources, Radisson Mining, Collective Mining and more
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments lithium Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
by
Tags:
Leave a Reply